NO20062515L - Faststoffpreparat som omfatter en insulinsensibilisator, en insulinsekretagog og en polyoksyetylensorbitanfettsyreester - Google Patents

Faststoffpreparat som omfatter en insulinsensibilisator, en insulinsekretagog og en polyoksyetylensorbitanfettsyreester

Info

Publication number
NO20062515L
NO20062515L NO20062515A NO20062515A NO20062515L NO 20062515 L NO20062515 L NO 20062515L NO 20062515 A NO20062515 A NO 20062515A NO 20062515 A NO20062515 A NO 20062515A NO 20062515 L NO20062515 L NO 20062515L
Authority
NO
Norway
Prior art keywords
insulin
secretary
fatty acid
acid ester
polyoxyethylene sorbitan
Prior art date
Application number
NO20062515A
Other languages
English (en)
Other versions
NO340294B1 (no
Inventor
Kazuhiro Doken
Tetsuya Kawano
Hioyoshi Koyama
Naoru Hamaguchi
Original Assignee
Takeda Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34543966&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20062515(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Takeda Pharmaceutical filed Critical Takeda Pharmaceutical
Publication of NO20062515L publication Critical patent/NO20062515L/no
Publication of NO340294B1 publication Critical patent/NO340294B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/64—Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)

Abstract

Et fast preparat som er nyttig som diabetesbehandlingsmiddel eller lignende og som har utmerkete oppløsningsegenskaper for en insulinsensitiserer og en insulinsekretagog . Fortrinnsvis omfatter preparatet en insulinsensitiserer, en insulinsekretagog og en polyoksyetylensorbitanfettsyreester.
NO20062515A 2003-10-31 2006-05-31 Fast preparat omfattende pioglitazon eller et salt derav, glimepirid og polyoksyetylensorbitanfettsyreester NO340294B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2003371679 2003-10-31
PCT/JP2004/015958 WO2005041962A1 (en) 2003-10-31 2004-10-21 Solid preparation comprising an insulin sensitizer, an insulin secretagogue and a polyoxyethylene sorbitan fatty acid ester

Publications (2)

Publication Number Publication Date
NO20062515L true NO20062515L (no) 2006-07-31
NO340294B1 NO340294B1 (no) 2017-03-27

Family

ID=34543966

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20062515A NO340294B1 (no) 2003-10-31 2006-05-31 Fast preparat omfattende pioglitazon eller et salt derav, glimepirid og polyoksyetylensorbitanfettsyreester

Country Status (28)

Country Link
US (1) US7700128B2 (no)
EP (1) EP1677792B1 (no)
KR (2) KR100952090B1 (no)
CN (1) CN1874774B (no)
AR (1) AR046210A1 (no)
AU (1) AU2004285354B2 (no)
BR (1) BRPI0414979A (no)
CA (1) CA2540225C (no)
CY (1) CY1117176T1 (no)
DK (1) DK1677792T3 (no)
ES (1) ES2556244T3 (no)
GE (1) GEP20084570B (no)
HR (1) HRP20151447T1 (no)
HU (1) HUE028576T2 (no)
IL (1) IL174201A (no)
JO (1) JO3106B1 (no)
MA (1) MA28116A1 (no)
MX (1) MXPA06004639A (no)
NO (1) NO340294B1 (no)
NZ (1) NZ546337A (no)
PE (1) PE20050923A1 (no)
PL (1) PL1677792T3 (no)
PT (1) PT1677792E (no)
RU (1) RU2359661C2 (no)
SI (1) SI1677792T1 (no)
TW (1) TWI339586B (no)
WO (1) WO2005041962A1 (no)
ZA (1) ZA200602056B (no)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050220881A1 (en) * 2003-10-10 2005-10-06 Bvm Holding Co. Pharmaceutical composition
MXPA05013220A (es) * 2005-12-06 2007-06-05 Leopoldo De Jesus Espinosa Abdala Composiciones farmaceuticas que comprenden sustancias antidiabeticas combinadas para su uso en diabetes mellitus tipo 2.
CA2633149C (en) * 2005-12-22 2015-06-30 Takeda Pharmaceutical Company Limited Solid preparation containing an insulin sensitizer
US20100237530A1 (en) * 2006-06-27 2010-09-23 Daiichi Sankyo Company, Limited Compressed preparation
UA95828C2 (ru) * 2007-02-01 2011-09-12 Такеда Фармасьютикал Компани Лимитед Твердая рецептура, которая содержит алоглиптин и пиоглитазон
IS8660A (is) * 2007-07-02 2009-01-03 Actavis Group Ptc Ehf. Gliklasíð lyfjasamsetning
EP2190417A2 (en) * 2008-03-26 2010-06-02 Teva Pharmaceutical Industries Ltd. Pharmaceutical compositions comprising insulin sensitizer and insulin secretagogue
US20100256196A1 (en) 2008-12-04 2010-10-07 Ikfe Biomarkers for Atherosclerosis
US20110118134A1 (en) 2008-12-11 2011-05-19 Ikfe Gmbh Biomarkers for insulin sensitizer drug response
WO2010076655A1 (en) 2008-12-30 2010-07-08 Ikfe Gmbh Biomarkers for adipose tissue activity
US20100210541A1 (en) 2009-01-07 2010-08-19 Andreas Pfuetzner Biomarkers for Appetite Regulation
CA2754950A1 (en) * 2009-03-20 2010-09-23 Smartcells, Inc. Terminally-functionalized conjugates and uses thereof
MX363549B (es) * 2010-09-21 2019-03-26 Intekrin Therapeutics Inc Star Composiciones farmacéuticas sólidas antidiabéticas.
EP2438911A1 (en) 2010-10-08 2012-04-11 LEK Pharmaceuticals d.d. Pharmaceuticals compositions comprising sulphonylurea-class insulin secretagogue and polyethylene glycol castor oil
WO2013034174A1 (en) * 2011-09-06 2013-03-14 ZENTIVA Saglik Ürünleri Sanayi ve Ticaret A.S. Solid preparations of pioglitazone and glimepiride
CN104288161A (zh) * 2014-09-19 2015-01-21 四川海思科制药有限公司 一种含吡格列酮格列美脲的药物组合物
CA2979033A1 (en) 2015-03-09 2016-09-15 Intekrin Therapeutics, Inc. Methods for the treatment of nonalcoholic fatty liver disease and/or lipodystrophy
US11253508B2 (en) 2017-04-03 2022-02-22 Coherus Biosciences, Inc. PPARy agonist for treatment of progressive supranuclear palsy

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5865213A (ja) * 1981-10-13 1983-04-18 Tokai Kapuseru Kk ｄｌ−２−（４，８，１２−トリメチルトリデシル）−２，５，７，８−テトラメチル−６−クロマニルニコチネ−ト軟カプセル剤
US4620974A (en) * 1983-07-07 1986-11-04 American Home Products Corporation Pharmaceutical composition containing a liquid lubricant
JP2764274B2 (ja) * 1988-03-28 1998-06-11 株式会社ミドリ十字 医薬組成物
DK0726761T3 (da) 1993-11-03 2001-06-18 Isomed Inc Mikropartikulære farmaceutiske præparater på micel-form
HU212428B (en) * 1994-05-13 1996-06-28 Egyt Gyogyszervegyeszeti Gyar Process to prepare pharmaceutical compositions containing gemfibrozyl
TWI238064B (en) * 1995-06-20 2005-08-21 Takeda Chemical Industries Ltd A pharmaceutical composition for prophylaxis and treatment of diabetes
EP0862562B1 (en) 1995-09-13 2001-07-04 Takeda Chemical Industries, Ltd. Benzoxazepine compounds, their production and use as lipid lowering agents
GB9619757D0 (en) 1996-09-21 1996-11-06 Knoll Ag Chemical process
FR2758461A1 (fr) * 1997-01-17 1998-07-24 Pharma Pass Composition pharmaceutique presentant une biodisponibilite elevee et son procede de preparation
US5859037A (en) 1997-02-19 1999-01-12 Warner-Lambert Company Sulfonylurea-glitazone combinations for diabetes
US6011049A (en) 1997-02-19 2000-01-04 Warner-Lambert Company Combinations for diabetes
US6291495B1 (en) 1997-02-24 2001-09-18 Robert B. Rieveley Method and composition for the treatment of diabetes
US6057338A (en) 1997-04-04 2000-05-02 Merck & Co., Inc. Somatostatin agonists
US6025372A (en) 1997-04-04 2000-02-15 Merck & Co., Inc. Somatostatin agonists
NZ501163A (en) * 1997-06-18 2002-02-01 Smithkline Beecham P Treatment of diabetes with thiazolidinedione and sulphonylurea (glibenclamide, glipizide, gliclazide, glimepiride, tolazamide and tolbutamide
GB9715306D0 (en) 1997-07-18 1997-09-24 Smithkline Beecham Plc Novel method of treatment
GB9715298D0 (en) 1997-07-18 1997-09-24 Smithkline Beecham Plc Novel method of treatment
GB9715295D0 (en) 1997-07-18 1997-09-24 Smithkline Beecham Plc Novel method of treatment
AU9062998A (en) * 1997-09-11 1999-03-29 Nycomed Danmark A/S Modified release multiple-units compositions of non-steroid anti-inflammatory drug substances (nsaids)
WO1999022735A1 (en) 1997-10-30 1999-05-14 Merck & Co., Inc. Somatostatin agonists
EA007610B1 (ru) 1998-11-12 2006-12-29 Смитклайн Бичам Плс Таблетка с энтеропокрытием, обеспечивающая отсроченное высвобождение
AR035016A1 (es) 1999-08-25 2004-04-14 Takeda Chemical Industries Ltd Composicion de azol promotor de produccion/secrecion de neurotrofina, compuesto prodroga del mismo, composicion farmaceutica que lo comprende y uso del mismo para preparar esta ultima.
WO2001025228A1 (fr) 1999-10-07 2001-04-12 Tadeka Chemical Industries, Ltd. Derives d'amines
US20030180352A1 (en) 1999-11-23 2003-09-25 Patel Mahesh V. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
US6793934B1 (en) * 1999-12-08 2004-09-21 Shire Laboratories, Inc. Solid oral dosage form
US20010036479A1 (en) 2000-01-14 2001-11-01 Gillian Cave Glyburide composition
ATE479429T1 (de) 2000-04-28 2010-09-15 Takeda Pharmaceutical Antagonisten des melanin-konzentrierenden hormons
US6524621B2 (en) 2000-05-01 2003-02-25 Aeropharm Technology Inc. Core formulation
US7229986B2 (en) 2000-05-16 2007-06-12 Takeda Pharmaceutical Company Ltd. Melanin-concentrating hormone antagonist
CA2434169C (en) 2001-01-12 2011-03-15 Sun Pharmaceutical Industries Limited Spaced drug delivery system
WO2003042204A1 (fr) 2001-10-19 2003-05-22 Takeda Chemical Industries, Ltd. Derive d'amine
US6682759B2 (en) * 2002-02-01 2004-01-27 Depomed, Inc. Manufacture of oral dosage forms delivering both immediate-release and sustained-release drugs
CN100367960C (zh) 2002-07-11 2008-02-13 武田药品工业株式会社 包衣制剂的制备方法
UA80991C2 (en) 2002-10-07 2007-11-26 Solid preparation containing an insulin resistance improving drug and an active ingredient useful as a remedy for diabetes
US20040147564A1 (en) 2003-01-29 2004-07-29 Rao Vinay U. Combinations of glimepiride and the thiazolidinedione for treatment of diabetes
US7976853B2 (en) 2003-01-29 2011-07-12 Takeda Pharmaceutical Company Limited Process for producing coated preparation
FR2853831A1 (fr) * 2003-03-05 2004-10-22 Usv Ltd Forme posologique solide a usage oral de metformine et de glyburide et son procede de preparation

Also Published As

Publication number Publication date
PE20050923A1 (es) 2005-12-26
MXPA06004639A (es) 2006-06-27
WO2005041962A1 (en) 2005-05-12
CA2540225A1 (en) 2005-05-12
CA2540225C (en) 2012-03-06
CY1117176T1 (el) 2017-04-05
IL174201A (en) 2011-04-28
US7700128B2 (en) 2010-04-20
CN1874774B (zh) 2011-04-13
AR046210A1 (es) 2005-11-30
GEP20084570B (en) 2008-12-25
PT1677792E (pt) 2016-02-09
KR100952090B1 (ko) 2010-04-13
AU2004285354A1 (en) 2005-05-12
MA28116A1 (fr) 2006-08-01
BRPI0414979A (pt) 2006-11-21
RU2359661C2 (ru) 2009-06-27
ZA200602056B (en) 2007-05-30
KR20060061383A (ko) 2006-06-07
SI1677792T1 (sl) 2016-02-29
EP1677792A1 (en) 2006-07-12
NO340294B1 (no) 2017-03-27
JO3106B1 (ar) 2017-09-20
US20060223870A1 (en) 2006-10-05
PL1677792T3 (pl) 2016-05-31
ES2556244T3 (es) 2016-01-14
TW200524641A (en) 2005-08-01
IL174201A0 (en) 2006-08-01
DK1677792T3 (en) 2015-12-14
KR20100012105A (ko) 2010-02-05
RU2006118786A (ru) 2007-12-10
HRP20151447T1 (hr) 2016-02-12
EP1677792B1 (en) 2015-11-18
AU2004285354B2 (en) 2009-09-17
TWI339586B (en) 2011-04-01
NZ546337A (en) 2009-03-31
CN1874774A (zh) 2006-12-06
HUE028576T2 (en) 2016-12-28

Similar Documents

Publication Publication Date Title
NO20062515L (no) Faststoffpreparat som omfatter en insulinsensibilisator, en insulinsekretagog og en polyoksyetylensorbitanfettsyreester
CR8402A (es) Indazol-o-glucosidos sustitutos
NO20074908L (no) Preparater inneholdende fettsyrer og/eller derivater derav og et lavtemperatur-stabiliseringsmiddel
WO2005012243A3 (en) Substituted indole-o-glucosides
AU2009296340B2 (en) Glyphosate formulations containing amidoalkylamine surfactants
DK1797281T3 (da) Fremgangsmåde til at estimere et bruds geometri, såvel som sammensætninger og artikler anvendt dertil
BRPI0612409B8 (pt) composições de tensoativos à base de ácido peroxicarboxílico e método de reduzir a população de microorganismos em um objeto
GT200600426A (es) Formulacion novedosa
BRPI0706947A8 (pt) método de preparação de uma composição à base de proteína, e, método de preparação de micropartículas baseadas em proteínas
RS50660B (sr) Dihidrotetrabenazini i farmaceutske kompozicije koje ih sadrže
NO20091700L (no) Florizinanaloger som inhibitorer av glukose-ko-transporter 2
WO2007067782A3 (en) Compositions and methods for inducing the activation of immature monocytic dendritic cells
CR9730A (es) Mezclas fungicidas que contienen anilidas sustituidas de acido 1-metilpirazol-4-ilcarboxilico
WO2007012979A3 (en) Polylactide compositions and uses thereof
WO2007096711A3 (en) Multipurpose, non-corrosive cleaning compositions and methods of use
CR10937A (es) Inhibidores de cinasa mapk/erk
BR0305767A (pt) Métodos e composições para a preparação de derivados de ácido 4-substituìdo 3-hidroxibutìrico
WO2007019526A3 (en) Compositions and methods for controlling glucose and lipid uptake from foods
TW200711663A (en) Emulsifier system, emulsion and use thereof
ATE464307T1 (de) Mif-hemmer
DK1758555T3 (da) Triterpenholdigt oleogeldannende middel, triterpenholdig oleogel og fremgangsmåde til fremstilling af en triterpenholdig oleogel
WO2007053424A3 (en) Silicone vesicles containing actives
BRPI0719272A2 (pt) Composição de enzima, e, método para preparar uma composição de enzima.
WO2008085991A3 (en) Reaction chamber
WO2008023181A3 (en) A sliding support assembly